Bristol-Myers Squibb Aktie
WKN: 850501 / ISIN: US1101221083
31.07.2025 13:46:07
|
Bristol-Myers Squibb Co. Q2 Profit Decreases, But Beats Estimates
(RTTNews) - Bristol-Myers Squibb Co. (BMY) released a profit for second quarter that Decreased from last year but beat the Street estimates.
The company's earnings came in at $1.310 billion, or $0.64 per share. This compares with $1.680 billion, or $0.83 per share, last year.
Excluding items, Bristol-Myers Squibb Co. reported adjusted earnings of $2.985 billion or $1.46 per share for the period.
Analysts on average had expected the company to earn $1.10 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 0.6% to $12.269 billion from $12.201 billion last year.
Bristol-Myers Squibb Co. earnings at a glance (GAAP) :
-Earnings: $1.310 Bln. vs. $1.680 Bln. last year. -EPS: $0.64 vs. $0.83 last year. -Revenue: $12.269 Bln vs. $12.201 Bln last year.
-Guidance: Full year EPS guidance: $6.35 - $6.65 Full year revenue guidance: $46.5 - $47.5 Bln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bristol-Myers Squibb Co.mehr Nachrichten
Analysen zu Bristol-Myers Squibb Co.mehr Analysen
Aktien in diesem Artikel
Bristol-Myers Squibb Co. | 38,60 | -0,77% |
|